Skip to main content

Year: 2026

Lithium Ionic Announces Date for Annual and Special Meeting Of Shareholders

TORONTO, May 22, 2026 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) set August 18, 2026, for its annual general and special meeting (“AGM”), when it will also fulfil the requisition of Waratah Capital Advisors Ltd. (“Waratah”) for a shareholder meeting to address board renewal. On recommendation of Lithium Ionic’s special committee, the board of the Company has called the shareholder meeting to address typical annual matters, including the election of members of the board of directors for the ensuing year. The Company anticipates continued discussion with representatives of Waratah and other shareholders to identify further directors for nomination. Shareholders will be aware that certain directors have ceased to be members of the Company’s board of directors and have...

Continue reading

Brøndby IF ansætter Julius Ohnesorge som fodbolddirektør og ophæver samarbejdet med Steve Cooper og Alan Tate

BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 Brøndby, den 22. maj 2026 SELSKABSMEDDELELSE NR. 4/2026Brøndby IF ansætter Julius Ohnesorge som fodbolddirektør og ophæver samarbejdet med Steve Cooper og Alan Tate Brøndby IF har i dag indgået en aftale med Julius Ohnesorge, der tiltræder i rollen som fodbolddirektør dags dato. Brøndby IF har endvidere i dag ophævet samarbejdet med cheftræner Steve Cooper og assistenttræner Alan Tate med øjeblikkelig virkning. Brøndby IFBestyrelsenInformationYderligere information om denne meddelelse kan fås hos kommunikationsdirektør Søren Hanghøj på 25 45 68 68.AttachmentFBM nr 4 2026 Brøndby IF

Continue reading

Air Canada Reaches Tentative Contract Agreement with Unifor

Agreement covers 6,000 airport and customer service employees MONTREAL, May 22, 2026 (GLOBE NEWSWIRE) — Air Canada today said it has reached a tentative collective agreement with Unifor, representing approximately 6,000 contact centre, customer relations, concierge, airport in-terminal and customer journey management employees at Air Canada. The tentative agreement recognizes the contributions and professionalism of Air Canada’s frontline airport and customer service agents, while providing a framework for the future growth of the airline. Terms of the new agreement will remain confidential pending a ratification vote by the membership, expected to be completed over the next month, and approval by the Air Canada Board of Directors. About Air Canada Air Canada is Canada’s largest airline, the country’s flag carrier...

Continue reading

Ninepoint Partners Announces May 2026 Cash Distributions for its ETFs and ETF Series Securities

TORONTO, May 22, 2026 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the May 2026 cash distributions for its ETFs and ETF Series securities. The record date for the distributions is May 29, 2026. All distributions are payable on June 5, 2026. The per-unit May 2026 distributions are detailed below:Ninepoint ETF Series Ticker Distribution per unit Notional Distribution per unit CUSIPNinepoint Diversified Bond Fund NBND $ 0.058286 $ 0.000000 65443H100Ninepoint Alternative Credit Opportunities Fund NACO $ 0.099331 $ 0.000000 65443Q100Ninepoint Energy Income Fund NRGI $ 0.222360 $ 0.000000 65444A104Ninepoint Target Income Fund TIF $ 0.082040 $ 0.000000 65446C108Ninepoint Global Infrastructure Fund INFR $ 0.072246 $ 0.000000 65443G102Ninepoint Balanced+ Fund NBAL $ 0.090290 $ 0.000000 65443K103Ninepoint...

Continue reading

REV Closes Deal With Major Gold on Quebec Mining Claims

REV Corporate Video: https://youtu.be/biOHmBtI8ns VANCOUVER, British Columbia, May 22, 2026 (GLOBE NEWSWIRE) — REV Exploration Corp. (“REV” or the “Company”) (TSXV: REVX; OTC: REVFF; FSE: 7FF) is pleased to announce that, further to its February 19, 2026 news release, it has closed the disposition of certain mining claims held by the Company in Quebec (the “Purchased Assets”) (the “Transaction”), pursuant to an asset purchase agreement between the Company and Major Gold Corp. (“MGC”) dated February 19, 2026 (the “Asset Purchase Agreement”) for a purchase price of $1,240,000 of share consideration (the “Purchase Price”). Commenting on the Transaction, Jordan Potts, CEO and Director of REV, stated: “REV is pleased to complete this transaction with Major Gold, which we believe provides a pathway for these assets to continue to be...

Continue reading

Leo International Precision Health AG approves cash capital increase excluding subscription rights

Leo International Precision Health AG / Keyword: Capital measures / Capital increase Leo International Precision Health AG approves cash capital increase excluding subscription rights 22. May 2026 / 20:04 CET/CESTDisclosure of an inside information acc. to Article 17 of the Regulation (EU) No 596/2014, transmitted by GlobeNewswire.The issuer is solely responsible for the content of this announcement.The management board and the supervisory board of Leo International Precision Health AG (ISIN DE0005490601, WKN 549060, ticker symbol LEOW, „Company“) resolved today to increase the Company’s share capital by approximately 4.2 % against cash contributions through the issuance of 24,000 new no-par bearer shares of the Company (“New Shares”), utilizing a portion of the authorized capital 2025 and excluding shareholders’ subscription...

Continue reading

Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1)

Wegovy® 7.2 mg in a single-dose pen has now been recommended by CHMP for approval in the EU Novo Nordisk expects to launch Wegovy® 7.2 mg in a single-dose pen in the EU in Q3 2026 In the STEP UP trial, Wegovy® 7.2 mg demonstrated an average weight loss of 20.7%1, and around one-third of patients achieved 25% or greater weight loss Wegovy® 7.2 mg is already available in the U.S. for adults living with obesity under the brand name Wegovy® HDBagsværd, Denmark, 22 May 2026 – Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorisation of Wegovy® 7.2 mg (once-weekly injectable semaglutide 7.2 mg) in a single-dose pen for people living with obesity. Wegovy® 7.2 mg is already available in the EU for...

Continue reading

Ninepoint Partners Announces Estimated May 2026 Cash Distributions for Ninepoint Cash Management Fund – ETF Series

TORONTO, May 22, 2026 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the estimated May 2026 cash distribution for the ETF Series of Ninepoint Cash Management Fund (the “Fund”). Ninepoint Partners expects to issue a press release on or about May 28, 2026, which will provide the final distribution rate. The record date for the cash distribution is May 29, 2026, payable on June 5, 2026. All estimates in this document are based on the accounting data as of May 21, 2026. Due to subscriptions and/or redemptions and/or other factors, the final May 2026 distribution may differ from these estimates and the difference could be material. The information included in this letter is for reference purposes only. Please reconcile all information against your official client statements. This is not intended to be...

Continue reading

NevGold Congratulates Perpetua Resources On US$2.9 Billion Loan for the Gold-Antimony Stibnite Project in Idaho; NevGold Rapidly Advancing its At-Surface Oxide, Antimony-Gold Limo Butte Project to Near-Term U.S. Production

Vancouver, British Columbia, May 22, 2026 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) congratulates Perpetua Resources Corp. (TSX:PPTA, NASDAQ:PPTA, “Perpetua”) on the approved US$2.9 billion senior secured project loan from the Export-Import Bank of the United States (“EXIM”) (see Perpetua Resources News Release from May 21, 2026) under the “Make More in America Initiative”. The loan supports the development of the Stibnite gold‑antimony project in Idaho and represents a major commitment by the U.S. Government to rebuilding a secure domestic antimony supply chain. Perpetua’s Stibnite Project is currently the only large-scale, domestic resource of the Critical Mineral antimony. NevGold is rapidly advancing its maiden antimony-gold Mineral Resource Estimate (“MRE”) at the...

Continue reading

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the “Board”) approved a dividend of Semnur Pharmaceuticals, Inc. (“Semnur”) (OTC: SMNR) common stock held by the Company to its stockholders and certain other eligible equityholders of Scilex (collectively, the “Participating Holders”). The record date for the dividend is June 1, 2026 (the “Record Date”). The Participating Holders as of the Record Date will be entitled to receive one (1) share of common stock of Semnur for each share of Scilex common...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.